ABC.N
Latest Trade
96.07USDChange
1.48(+1.56%)Volume
384,890Today's Range
-
96.4852 Week Range
-
106.33As of on the New York Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 94.59 |
|---|---|
Open | 94.08 |
Volume | 384,890 |
3M AVG Volume | 18.57 |
Today's High | 96.48 |
Today's Low | 94.04 |
52 Week High | 106.33 |
52 Week Low | 72.20 |
Shares Out (MIL) | 204.14 |
Market Cap (MIL) | 19,536.37 |
Forward P/E | -- |
Dividend (Yield %) | 1.76 |
Amerisourcebergen Units Entered Amended & Restated Receivables Sale Agreement
HHS Says Gilead Anticipates Producing Sufficient Quantities Of Veklury To Meet Current Needs
U.S. States Seek $26.4 Bln From Drug Companies In Opioid Litigation - WSJ
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers. Servicing healthcare providers in the pharmaceutical supply channel, the Pharmaceutical Distribution segment's operations provide drug distribution and related services. The Other segment consists of the operations of various segments, including the AmerisourceBergen Consulting Services (ABCS), the World Courier Group, Inc. and the MWI Veterinary Supply, Inc. ABSG operates distribution facilities that focus primarily on complex disease treatment regimens.
Industry
Biotechnology & Drugs
Contact Info
1300 Morris Dr
CHESTERBROOK, PA
19087-5594
United States
+1.610.7277000
Executive Leadership
Steven H. Collis
Chairman of the Board, President, Chief Executive Officer
James F. Cleary
Chief Financial Officer, Executive Vice President
Silvana Battaglia
Chief Human Resource Officer, Executive Vice President
Gina K. Clark
Executive Vice President, Chief Communications & Administration Officer
John G. Chou
Executive Vice President, Chief Legal Officer and Secretary
Price To Earnings (TTM) | 12.64 |
|---|---|
Price To Sales (TTM) | 0.10 |
Price To Book (MRQ) | 5.06 |
Price To Cash Flow (TTM) | 9.78 |
Total Debt To Equity (MRQ) | 107.34 |
LT Debt To Equity (MRQ) | 93.87 |
Return on Investment (TTM) | 16.08 |
Return on Equity (TTM) | 3.98 |
Drug wholesaler AmerisourceBergen Corp and some of its executives and directors must face a shareholder lawsuit over its sale of unsterile chemotherapy drugs and payments of kickbacks to doctors, which have already resulted in $885 million in criminal and civil penalties...
* U.S. STATES SEEK $26.4 BILLION FROM DRUG COMPANIES IN OPIOID LITIGATION- WSJ
* AMERISOURCEBERGEN SELECTED BY DECIPHERA PHARMACEUTICALS TO SUPPORT QINLOCK™ Source text for Eikon: Further company coverage:
* AMERISOURCEBERGEN PRICES $500 MILLION 2.800% SENIOR NOTES DUE 2030 Source text for Eikon: Further company coverage:
* AMERISOURCEBERGEN REPORTS FISCAL 2020 SECOND QUARTER RESULTS
AmerisourceBergen Corp <ABC.N>, one of the largest U.S. drug distributors, has approached Walgreens Boots Alliance Inc <WBA.O> to explore a deal for its pharmaceutical wholesaling division, people familiar with the matter said on Monday.
* PROXY ADVISORY FIRM PIRC RECOMMENDS AMERISOURCEBERGEN CORP SHAREHOLDERS TO VOTE AGAINST RESOLUTION TO ELECT CEO STEVEN H COLLIS AS DIRECTOR
Vice-Chancellor Travis Laster of Delaware Chancery Court signaled Wednesday that he really did intend to reset the course of books-and-records litigation when he ruled last month that the wholesale pharmaceutical distributor AmerisourceBergen give shareholders formal board...
There is a reasonable possibility, according to Vice-Chancellor Travis Laster, that shareholders of the wholesale pharmaceutical distributor AmerisourceBergen Corporation will turn out to have an actionable claim that the company’s directors breached their fiduciary duties...
AmerisourceBergen has lost a bid to keep secret material related to the drug distributor's internal program for monitoring for suspicious orders in a lawsuit by New York's attorney general accusing the company of fueling the opioid epidemic.
AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, will pay $625 million to resolve civil fraud charges over the sale of syringes containing drugs for cancer patients, double billing, and providing kickbacks to doctors.
AmerisourceBergen Corp will pay the U.S. government and various states $625 million to resolve claims over the illegal distribution of adulterated and misbranded drugs, New York Attorney General Barbara Underwood said on Monday.
Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.
Drug wholesale distributor AmerisourceBergen Corp said on Thursday it had received a grand jury subpoena from federal prosecutors in Florida seeking documents related to opioid products and its communications with a drugmaker.
Drug distributor AmerisourceBergen Corp <ABC.N> posted a better-than-expected quarterly profit on Wednesday and said it expects its Memphis facility to be fully operational by fiscal 2019, sending its shares up 5 percent.
* AMERISOURCEBERGEN REPORTS FISCAL 2018 SECOND QUARTER RESULTS
Drug distributor AmerisourceBergen Corp on Wednesday posted a 30 percent fall in second-quarter profit hurt by high operating expenses.
* PRODUCTION AT PHARMEDIUM'S MEMPHIS OUTSOURCING FACILITY REMAINS VOLUNTARILY SUSPENDED
Kentucky's attorney general on Thursday sued AmerisourceBergen Corp, accusing the drug distributor of contributing to opioid abuse in the state by filling suspiciously large or frequent pharmacy orders of prescription painkillers.
* AMERISOURCEBERGEN SAYS STOCKHOLDERS REJECTED PROPOSAL TO URGE BOARD TO REPORT ON GOVERNANCE MEASURES IMPLEMENTED RELATED TO OPIOIDS - SEC FILING Source text: (http://bit.ly/2HZhCXW) Further company coverage:
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.